People: Dyax Corp (DYAX.O)
2 Dec 2013
Dr. Ron Cohen, M.D., has been appointed as Independent Director of Dyax Corp., effective November 01, 2011. Dr. Cohen has been President and Chief Executive Officer of Acorda Therapeutics, Inc. since the company was founded in 1995. Dr. Cohen received his B.A. degree with honors in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons and is Board Certified in Internal Medicine. Dr. Cohen previously was a Director and Chairman of the New York Biotechnology Association. He currently serves as a member of the Executive Committee and as Chairman of the Emerging Company Section of the board of the Biotechnology Industry Organization (BIO). He also serves as a member of the Columbia-Presbyterian Health Sciences Advisory Council.
|Total Annual Compensation,||Long-Term Incentive Plans,||All Other,||Fiscal Year Total,|